|
Dr. Carl W. Balezentis (age 50) President Enzo Life Sciences Inc. has held this position since June 2006. Before his employment with Enzo he was CEO of Lark Technologies Inc. from 2000 to 2004 prior to its acquisition by Genaissance Pharmaceuticals Inc. Subsequent to the acquisition he held the positions of President of Lark Technologies Inc. and Senior Vice President of Genaissance. From 1998 to 2000 he has held numerous executive positions in the life sciences industry at Sigma-Aldrich Perceptive Scientific Instruments Inc. Applied Biosystems Inc. (now Applera) and Promega Corporation. Dr. Balezentis holds a Ph.D. in Genetics from the University of Arizona and completed a Post Doctoral Fellowship at M.D. Anderson Cancer Center in Houston TX. | 